Alarming Increase in Hospitalizations of Children Due to E-Cigarettes

Regulations by 2FIRSTS.ai
Apr.22.2024
Alarming Increase in Hospitalizations of Children Due to E-Cigarettes
Shocking increase in hospitalizations among children under five due to e-cigarette use, according to latest NHS data.

According to a report from the UK media outlet "Wales Online" on April 22, the latest data released by the UK National Health Service shows a shocking increase in the proportion of boys and girls under the age of five requiring hospitalization due to severe illnesses caused by the use of e-cigarettes, with a 733% increase compared to previous years. The number of visits by teenagers under the age of 20 has increased by more than seven times in the past four years.

 

In 2020, no children required medical treatment due to using e-cigarettes, but only six adolescents needed medical assistance. According to data from the National Health Service in England, since 2020, there has been a 276% increase in the number of males and females seeking medical care for illnesses caused by e-cigarettes.

 

According to this statistics, in 2020, children accounted for only 6% of total hospital visits, but shockingly, last year, 14% of the 365 hospitalizations related to e-cigarettes were cases of teenagers aged 19 and under. Between 2020 and 2024, the total number of children admitted to hospital for e-cigarette-related illnesses increased by 733%.

 

Jonathan Grigg, a pediatric respiratory medicine professor at Queen Mary University of London, believes that the increased use of e-cigarettes among children is due to the appealing flavors available and the government's allowance for the free sale of e-cigarettes in the market. In a 2023 academic paper, he warned that children using e-cigarettes are "more likely to start using tobacco.

 

He said, "The increase in hospital admissions was entirely predictable and is the result of the government allowing e-cigarettes to be sold for free - these e-cigarette flavors are highly attractive to children and young people, especially given the negative health effects of e-cigarettes.

 

Sarah MacFadyen, Policy and Public Affairs Manager at the British Asthma and Lung Association, expressed deep concern over these figures. "The British Asthma and Lung Association has emphasized our stance: the sale of e-cigarettes to children under 18 has already been banned, and we strongly oppose non-smokers, especially children, starting to use e-cigarettes. The government should take action to prevent the e-cigarette industry from selling products to children."

 

Data obtained by news agency SWNS shows that hospital admissions for individuals aged 20 and under have increased since 2024. Among them, there are more female patients than male patients. In 2020, female patients accounted for 46%, but this number increased to 57% last year.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
mperial Brands’ HY26 results point to a more selective NGP transition. The company is using cash flow from traditional tobacco to fund targeted investments in modern oral nicotine, heated tobacco and reusable vaping systems. Its decision to exit the legacy myblu vaping business in the U.S., while expanding Zone nicotine pouches. In Europe, Imperial’s NGP growth is being driven by a multi-category portfolio including blu, Pulze and Zone/Skruf.
Special Report
May.12
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
The U.S. Food and Drug Administration announced on May 6 that it has advanced its modernization initiative by launching Elsa 4.0, an upgraded internal AI tool, and consolidating more than 40 application and submission data sources, systems and portals into a new platform called HALO. FDA said the integration of HALO and Elsa will allow staff to query data and build workflows without manually uploading documents in each chat.
May.07 by 2FIRSTS.ai
Altria Announces Nationwide Retail Expansion of on! PLUS Nicotine Pouches
Altria Announces Nationwide Retail Expansion of on! PLUS Nicotine Pouches
Altria Group, Inc. announced the nationwide retail expansion of on! PLUS nicotine pouches, a product manufactured by Helix Innovations LLC, an Altria operating company. The product had already been available through e-commerce and participating retailers in North Carolina, Florida and Texas, began wholesale deliveries on March 16, 2026, and is expected to reach participating retailers nationwide starting March 23, 2026.
Mar.24 by 2FIRSTS.ai
UK Retailers Call on Government to Better Resource Trading Standards to Fight Illicit Tobacco and Vape Trade
UK Retailers Call on Government to Better Resource Trading Standards to Fight Illicit Tobacco and Vape Trade
Retailers in the UK have called on the government to provide greater resources to Trading Standards in response to the growing trade in illicit tobacco and vapes. Fed national vice-president Hemanshu Patel made the call during a panel discussion at the National Convenience Show in Birmingham on April 15.
Apr.21 by 2FIRSTS.ai
Product | Vaporless Mode + Transparent Display Screen: Kanger Launches Subox Mix 50K in the U.S.
Product | Vaporless Mode + Transparent Display Screen: Kanger Launches Subox Mix 50K in the U.S.
E-cigarette brand Kanger has recently launched its new e-cigarette, the Subox Mix 50K, across multiple online channels in the United States. The product features a “vaporless mode” and a transparent digital display design, supporting switching between approximately 25K vapor puffs and 25K vaporless puffs, for a total of 50,000 puffs, while displaying battery level and mode status in the transparent pod section.
Apr.13 by 2FIRSTS.ai
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.
Apr.23 by 2FIRSTS.ai